Back to search
FDAFDA · Food and drugs·Recall number D-0123-2018

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02

Published December 27, 2017 · Recall initiated: August 30, 2017

Summary

FDA records drug Class I recall D-0123-2018, published December 27, 2017 and initiated August 30, 2017. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 102,500 vials; Lot: Lot: 632153A; Exp. 03/18. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: glass particulate found in vial

What to do

Voluntary: Firm initiated · Press Release

Get an email if VANCOMYCIN HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VANCOMYCIN HYDROCHLORIDE
Manufacturer
Pfizer Inc.
Distributor
Nationwide USA and Puerto Rico
Lot
Lot: 632153A; Exp. 03/18
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02 recalled?

Yes. FDA published recall D-0123-2018 on December 27, 2017. Reported hazard: Presence of Particulate Matter: glass particulate found in vial

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VANCOMYCIN HYDROCHLORIDE.